Homepage
Foley Hoag Foley Hoag
Contact Us >>
Menu
  • Our People
  • Practices  
    • By A-Z
    • By Category
  • Industries  
    • Cannabis
    • Education
    • Energy & Climate
    • Healthcare
    • Investment Advisers & Private Funds
    • Life Sciences
    • Professional Services
    • Sovereign States
    • Technology
  • Publications  
    • Alerts & Updates
    • eBooks & White Papers
    • Blogs
  • News & Events  
    • News
    • Events
    • Media Center
  • Careers  
    • Lawyers
    • Technology Specialists
    • Paralegals
    • Business Professionals
    • Current Openings
    • Pro Bono
    • Summer Program
  • Our Firm  
    • History
    • Management Team
    • Pro Bono
    • Commitment to Diversity, Equity & Inclusion
    • Women's Forum
    • Lex Mundi
    • The Foley Hoag Foundation
    • Offices
    • Rankings and Accolades
FIND A LAWYER

FIND A LAWYER

  • Bio Folder (0)
    Save attorney bios to the Bio Folder to email page links or generate a PDF containing all of your saved pages.
  • Print
  • Text Size A

Industries

Healthcare Healthcare

Industry Resources
  • Overview
  • Work For Clients
  • People
  • Publications
  • In the News
  • Media Center
  • Represented CutisPharma, Inc., a specialty pharmaceutical company that develops and commercializes compounding kits that help patients who are unable to swallow conventional oral dosage forms such as tablets and capsules and recently launched FDA-approved drug Firvanq, in its sale to NovaQuest Capital Management, L.L.C.
  • Represented Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies (mAbs) for pre-emptive and post-infection treatment of serious infectious diseases, in the closing of its $45.5 million Series D financing. 
  • Succeeded in encouraging CMS to initiate a process to revise its outdated coverage policies for positron electronic tomography (PET) scans.
  • Represented multiple Fortune 100 employers to develop a successful strategy for complying with the Summary of Benefits and Coverage (SBC) provisions of Affordable Care Act, and worked with regulators to craft less-bureaucratic policies.  
  • Crafted legal arguments that persuaded CMS to update its policies regarding coverage and payment for complex molecular diagnostic tests.
  • Worked with two long-term care associations and their state Medicaid agencies to develop a workable strategy for providing home and community based services to elderly individuals who wanted to remain in the community.
  • Successfully represented an organization before CMS whose state Medicaid agency had mistakenly classified the organizations an institution for mental disease (IMD).
  • Successfully persuaded CMS to create a new technology add-on payment for a prescription drug administered in the inpatient setting, the first time in 15 years that CMS had ever adopted such a policy for an orally-administered drug.
  • Helped two start-up pharmaceutical companies develop a strategy for coverage of drugs used to treat patients with end-stage renal disease (ESRD) in a way that assured coverage even with the bundled payment system for dialysis services.
  • Helped a Medicare Advantage plan assess the HIPAA consequences of a data breach and develop a process for weighing the merits of disclosure.
  • Provided crisis counseling for a hospital management service organization whose clients had been accused by CMS of EMTALA violations.
  • Helped a Medicare Advantage plan secure designation by a state Medicaid agency and CMS as a dual-eligible special needs plan (Dual SNP).
  • Successfully persuaded a state Department of Public Health to ease its overly-restrictive interpretation of a physician gift ban on pharmaceutical and medical device manufacturers.
Foley Hoag

Attorney advertising. Prior results do not guarantee a similar outcome. Copyright Foley Hoag LLP. All rights reserved. Website by Boston Interactive

  • Like
  • Follow
  • LinkedIn
  • Share
  • Terms of Use
    • Our People
    • Industries
      • Cannabis
      • Education
      • Energy, Cleantech & Climate
      • Healthcare
      • Investment Advisers & Private Funds
      • Life Sciences
      • Professional Services
      • Sovereign States
      • Technology
    • Practices
      • Practices A-Z
      • Practices by Category
    • Publications
      • Alerts & Updates
      • eBooks & White Papers
    • News & Events
      • News
      • Events
      • Media Center
    • Blogs
      • Advertising and Marketing Law
      • Cannabis & the Law
      • Corporate Social Responsibility and the Law
      • Drug Pricing Policy Watch
      • Energy & Cleantech Counsel
      • IPO, Then What?
      • Law & the Environment
      • Massachusetts Labor & Employment Law
      • Massachusetts Noncompete Law
      • Medicaid & the Law
      • Security, Privacy and the Law
      • State AG Insights
      • Trademark & Copyright Law
      • White Collar Law & Investigations
    • Careers
      • Lawyers
      • Technology Specialists
      • Paralegals
      • Business Professionals
      • Current Openings
      • Pro Bono
      • Summer Program
    • Our Firm
      • History
      • Management Team
      • Pro Bono
      • Commitment to Diversity, Equity & Inclusion
      • Lex Mundi
      • The Foley Hoag Foundation
      • Offices
      • Rankings and Accolades
    • Legal Notice
Boston

Seaport West 155 Seaport Boulevard Boston, MA US 02210-2600

tel: 617.832.1000

fax: 617.832.7000

  • Directions »|
  • Details »
New York

1301 Avenue of the Americas New York, NY US 10019

tel: 646.927.5500

fax: 646.927.5599

  • Directions »|
  • Details »
Paris

153 rue du Faubourg Saint-Honoré 75008 Paris, France

tel: +33.01.70.36.61.30

fax: +33.01.70.36.61.31

  • Directions »|
  • Details »
Washington, D.C.

1717 K Street, N.W. Washington, D.C. US 20006-5350

tel: 202.223.1200

fax: 202.785.6687

  • Directions »|
  • Details »

Biography Folder

Use the folder to collect pages throughout our website. After selecting your pages, email the page links or generate a PDF containing all of your pages with the helpful options below.

Page: Office: Remove all
  • Email This List
  • Make a PDF of This List
Successfully sent an email.  
Send

Email Disclaimer

Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.

If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.

OK Cancel